Last $9.20 USD
Change Today -0.09 / -0.97%
Volume 962.6K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kurt A. Gustafson

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Spectrum Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 4 different industries.

See Board Relationships
46$2,438,679
As of Fiscal Year 2013

Background*

Mr. Kurt A. Gustafson has been the Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Spectrum Pharmaceuticals, Inc. since June 3, 2013. Mr. Gustafson served as the Chief Financial Officer of Halozyme Therapeutics, Inc. from May 15, 2009 to May 23, 2013 and also served as its Principal Accounting Officer and Vice President until May 23, 2013. He served as Vice President of Finance of Halozyme Therapeutics, Inc. since April 2009 and ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

Director
2014-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

MBA
University of California-Los Angeles
BA
North Park University

Other Affiliations*

Annual Compensation*

Salary$262,500
Bonus$200,000
Total Annual Compensation$462,500

Stock Options*

Restricted Stock Awards$821,000
All Other Compensation$45,924
Unexercisable Options250,000
Unexercisable Options Value$160,000
Total Value of Options$160,000
Total Number of Options250,000

Total Compensation*

Total Annual Cash Compensation$508,424
Total Short Term Compensation$462,500
Other Long Term Compensation$866,924
Total Calculated Compensation$2,438,679
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $9.20 USD -0.09

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
17.6M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.